FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: iferanserin

Sort
E.g., 2013-05-19
E.g., 2013-05-19
Enter a comma separated list of user names.

Ventrus BioSciences (VTUS) - PennyOmega.com Watch List for Monday Nov. 21, 2011
Posted by pennylynnomega on November 20th, 2011

VTUS, Ventrus BioSciences, Inc.

** VTUS reported that it has completed its acquisition of all rights and title to VEN 309 (iferanserin ointment for the topical treatment of symptomatic hemorrhoids) from the licensor, Sam Amer & Co.

Read More
comment 0
Share
Tags:
Ventrus Biosciences, VTUS, NASDAQ:VTUS, gastrointestinal disorders, iferanserin, National Institute of Diabetes and Digestive Kidney Diseases, Sam Amer & Co, symptomatic hemorrhoids, VEN 309

VTUS, CRWE, HCC, DFG, DOW Stock Market Report from CRWEFinance.com
Posted by austinmark on November 20th, 2011

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read full article at: http://crwefinance.com/21307/stock-alerts/vtus-crwe-hcc-dfg-dow-stock-ma...

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Read More
comment 0
Share
Tags:
VoIP, DOW Chemical, Crown Equity Holdings, NYSE:DOW, NYSE:HCC, NYSE:DFG, Crown Tele Services, Delphi, Ventrus Biosciences, NASDAQ:VTUS, gastrointestinal disorders, iferanserin, sam amr

VTUS, CRWE, HPQ, KBR, BBY Stock Market Update from PennyOtcStock.com
Posted by Steve Stock on November 20th, 2011

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read full article at: http://pennyotcstock.com/17891/stock-alerts/vtus-crwe-hpq-kbr-bby-stock-...

Read More
comment 0
Share
Tags:
VoIP, best, Crown Equity Holdings, nyse:bby, NYSE:HPQ, NYSE:KBR, Crown Tele Services, Ventrus Biosciences, Hewlett, NASDAQ:VTUS, gastrointestinal disorders, iferanserin, sam amr

VTUS, CRWE, AVTR, ENTG, UTIW Stock Market Report from CRWEPicks.com
Posted by stockrider on November 20th, 2011

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read full article at: http://crwepicks.com/19063/stck-alerts/vtus-crwe-avtr-entg-utiw-stock-ma...

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Read More
comment 0
Share
Tags:
VoIP, Avatar, Crown Equity Holdings, entegris, nasdaq:entg, Crown Tele Services, NASDAQ:AVTR, Ventrus Biosciences, Nasdaq:UTIW, UTi Worldwide, NASDAQ:VTUS, gastrointestinal disorders, iferanserin, sam amr

ADVERTISE WITH US